MassMutual Private Wealth & Trust’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.65K Buy
+716
New +$2.69K ﹤0.01% 1849
2026
Q2
– Sell
-581
Closed -$4.46K – 2432
2026
Q1
$4.46K Buy
+581
New +$5.39K ﹤0.01% 1724

Other funds holding FULC

MassMutual Private Wealth & Trust's FULC Position: Q3 2026 in Review

MassMutual Private Wealth & Trust opened a new position in Fulcrum Therapeutics (FULC) in Q3 2026: 716 shares worth $2.65K. The stake represents ﹤0.01% of the portfolio and ranks #1849 among its holdings. This is a return to the name: MassMutual Private Wealth & Trust previously reported a position in FULC as recently as Q1 2026.

MassMutual Private Wealth & Trust first reported a position in FULC in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.46K in Q1 2026. 151 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • MassMutual Private Wealth & Trust held 716 shares of Fulcrum Therapeutics worth $2.65K as of Q3 2026.
  • Fulcrum Therapeutics was a new MassMutual Private Wealth & Trust position in Q3 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1849 holding.
  • MassMutual Private Wealth & Trust first reported a position in Fulcrum Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • MassMutual Private Wealth & Trust's Fulcrum Therapeutics position peaked at $4.46K in Q1 2026.
  • 151 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.